相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inclisiran and cardiovascular events: a patient-level analysis of phase III trials
Kausik K. Ray et al.
EUROPEAN HEART JOURNAL (2023)
New Therapeutic Approaches to the Treatment of Dyslipidemia 2: LDL-C and Lp(a)
Kyung An Kim et al.
Journal of Lipid and Atherosclerosis (2023)
Black-Blood Contrast in Cardiovascular MRI
Markus Henningsson et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2022)
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia
Yajnavalka Banerjee et al.
EXPERT OPINION ON DRUG SAFETY (2022)
Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis
Paul Guedeney et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
Serial magnetic resonance imaging detects a rapid reduction in plaque lipid content under PCSK9 inhibition with alirocumab
Jie Sun et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2021)
Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3-5
Gustavo Lenci Marques et al.
SCIENTIFIC REPORTS (2021)
Ischemic Stroke
Steven K. Feske
AMERICAN JOURNAL OF MEDICINE (2021)
siRNA: Mechanism of action, challenges, and therapeutic approaches
Walhan Alshaer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
High levels of osteoprotegerin are associated with coronary artery calcification in patients suspected of a chronic coronary syndrome
Mirthe Dekker et al.
SCIENTIFIC REPORTS (2021)
Association between Serum Osteoprotegerin Levels and Severity of Coronary Artery Disease in Patients with Acute Myocardial Infarction
Yves Cottin et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Osteopontin in Cardiovascular Diseases
Kohsuke Shirakawa et al.
BIOMOLECULES (2021)
Evolocumab, a PCSK9-Monoclonal Antibody, Rapidly Reverses Coronary Artery Endothelial Dysfunction in People Living With HIV and People With Dyslipidemia
Thorsten M. Leucker et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
The Influence of Calcification Factors and Endothelial-Dysfunction Factors on the Development of Unstable Atherosclerotic Plaques
Yana V. Polonskaya et al.
DIAGNOSTICS (2020)
Elevated Osteoprotegerin Concentration Predicts Increased Risk of Cardiovascular Mortality in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Qing-xiu Huang et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2020)
Adverse Events Associated With PCSK9 Inhibitors: A Real-World Experience
Muhammed T. Gurgoze et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Emerging Magnetic Resonance Imaging Techniques for Atherosclerosis Imaging High Magnetic Field, Relaxation Time Mapping, and Fluorine-19 Imaging
Rob C. I. Wust et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Immunity and inflammation in atherosclerosis
D. Wolf et al.
HERZ (2019)
Osteopontin in Vascular Disease Friend or Foe?
Zoe Shin Yee Lok et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease
Gjin Ndrepepa
CLINICA CHIMICA ACTA (2019)
Association of soluble CD40L with short-term and long-term cardiovascular and all-cause mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study
Ingrid Gergei et al.
ATHEROSCLEROSIS (2019)
Efficacy of alirocumab for reducing plaque vulnerability: Study protocol for ALTAIR, a randomized controlled trial in Japanese patients with coronary artery disease receiving rosuvastatin
Hiromasa Otake et al.
JOURNAL OF CARDIOLOGY (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Inhibition of Aortic Calcification by Policosanol in Dyslipidemic Rabbits Is Enhanced by Pentoxifylline: Potential Role of PCSK9
Mohamed M. Elseweidy et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2018)
PCSK9 induces a pro-inflammatory response in macrophages
Chiara Ricci et al.
SCIENTIFIC REPORTS (2018)
Spotty Carotid Plaques Are Associated with Inflammation and the Occurrence of Cerebrovascular Symptoms
Sanela Halak et al.
CEREBROVASCULAR DISEASES EXTRA (2018)
Inflammatory processes in cardiovascular disease: a route to targeted therapies
Neil Ruparelia et al.
NATURE REVIEWS CARDIOLOGY (2017)
Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques
Sarah R. Langley et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia
G. Kees Hovingh et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2017)
New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway
Zhi-Han Tang et al.
ATHEROSCLEROSIS (2017)
Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension Studies
Peter P. Toth et al.
CIRCULATION (2017)
Prognostic value of PCSK9 levels in patients with acute coronary syndromes
Baris Gencer et al.
EUROPEAN HEART JOURNAL (2016)
Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney disease
Jing Chen et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2016)
Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials
Peter H. Jones et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease
William Herrington et al.
CIRCULATION RESEARCH (2016)
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients The GLAGOV Randomized Clinical Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Proprotein convertase subtilisin-kexin type 9 as a biomarker for the severity of coronary artery disease
Sha Li et al.
ANNALS OF MEDICINE (2015)
Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
Xin-Lin Zhang et al.
BMC MEDICINE (2015)
Circulating PCSK9 levels are positively correlated with NMR-assessed atherogenic dyslipidaemia in patients with high cardiovascular risk
Montse Guardiola et al.
CLINICAL SCIENCE (2015)
Carotid Intima-Media Thickness for Atherosclerosis
Tomohisa Nezu et al.
Journal of Atherosclerosis and Thrombosis (2015)
Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease
Sha Li et al.
ATHEROSCLEROSIS (2014)
Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima-media thickness
Changhong Tan et al.
ATHEROSCLEROSIS (2014)
Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease
Yan Zhang et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2014)
Overexpression of MMP-9 and Its Inhibitors in Blood Mononuclear Cells after Myocardial Infarction - Is It Associated with Depressive Symptomatology?
Simon Jonsson et al.
PLOS ONE (2014)
Characterization of Coronary Atherosclerosis by Magnetic Resonance Imaging
Marcus R. Makowski et al.
CIRCULATION (2013)
Plasma osteoprotegerin levels increase with the severity of cerebral artery atherosclerosis
Jinkwon Kim et al.
CLINICAL BIOCHEMISTRY (2013)
Osteoprotegerin in ST-elevation myocardial infarction: Prognostic impact and association with markers of myocardial damage by magnetic resonance imaging
Georg Fuernau et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease
Dimitris Tousoulis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Macrophages in atherosclerosis: a dynamic balance
Kathryn J. Moore et al.
NATURE REVIEWS IMMUNOLOGY (2013)
PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages
Zhihan Tang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
Evan A. Stein et al.
LANCET (2012)
Advances in noninvasive imaging for evaluating clinical risk and guiding therapy in carotid atherosclerosis
Andrew J. Degnan et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2012)
Monocyte and Macrophage Dynamics During Atherogenesis
Klaus Ley et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study
Annamaria Mazzone et al.
CORONARY ARTERY DISEASE (2011)
Effect of Two Intensive Statin Regimens on Progression of Coronary Disease
Stephen J. Nicholls et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Executive Summary: Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association
Donald Lloyd-Jones et al.
CIRCULATION (2010)
Magnetic Resonance Imaging of Carotid Atherosclerotic Plaque in Clinically Suspected Acute Transient Ischemic Attack and Acute Ischemic Stroke
Jaywant P. Parmar et al.
CIRCULATION (2010)
From Atherosclerosis to Acute Coronary Syndromes: The Role of Soluble CD40 Ligand
Dimitris Tousoulis et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2010)
Inflammation in Atherosclerosis From Pathophysiology to Practice
Peter Libby et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Carotid Artery Stenosis: Accuracy of Noninvasive Tests-Individual Patient Data Meta-Analysis
Francesca M. Chappell et al.
RADIOLOGY (2009)
Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis
F. J. Olson et al.
JOURNAL OF INTERNAL MEDICINE (2008)
From vulnerable plaque to atherothrombosis
T. Thim et al.
JOURNAL OF INTERNAL MEDICINE (2008)
The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability
Nikolaos P. E. Kadoglou et al.
JOURNAL OF VASCULAR SURGERY (2008)
Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans
Anders Vik et al.
ATHEROSCLEROSIS (2007)
Relation of osteoprotegerin to coronary calcium and aortic plaque (from The Dallas Heart Study)
Moeen Abedin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Osteopontin and carotid atherosclerosis in patients with essential hypertension
Mie Kurata et al.
CLINICAL SCIENCE (2006)
Elevated matrix metalloproteinase-9 associated with stroke or cardiovascular death in patients with carotid stenosis
Nikolaj Eldrup et al.
CIRCULATION (2006)
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis - The ASTEROID trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events - A prospective assessment with MRI - Initial results
N Takaya et al.
STROKE (2006)
Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris
D Fukuda et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice
PJ Gough et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque - Comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology
JM Cai et al.
CIRCULATION (2005)
Assessment of human atherosclerotic carotid plaque components with multisequence MR imaging: Initial experience
VC Cappendijk et al.
RADIOLOGY (2005)
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris
E Zouridakis et al.
CIRCULATION (2004)
Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis
J Golledge et al.
STROKE (2004)
Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease
S Kiechl et al.
CIRCULATION (2004)
From vulnerable plaque to vulnerable patient - A call for new definitions and risk assessment strategies: Part I
M Naghavi et al.
CIRCULATION (2003)
In vivo accuracy of multisequence MR imaging for identifying unstable fibrous caps in advanced human carotid plaques
LM Mitsumori et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2003)
Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging
JM Cai et al.
CIRCULATION (2002)
Development of atherosclerosis in osteopontin transgenic mice
S Chiba et al.
HEART AND VESSELS (2002)
Association between myeloperoxidase levels and risk of coronary artery disease
ZL Zhang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes
S Sugiyama et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Effects of immunosuppressants on receptor activator of NF-κB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells
LC Hofbauer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
The CD40/CD154 receptor/ligand dyad
U Schonbeck et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
分享论文
